Literature DB >> 16964215

Evidence and anecdotes: an analysis of human gene patenting controversies.

Timothy Caulfield1, Robert M Cook-Deegan, F Scott Kieff, John P Walsh.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16964215      PMCID： PMC2701726          DOI： 10.1038/nbt0906-1091

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  19 in total

1.  Data withholding in academic genetics: evidence from a national survey.

Authors:  Eric G Campbell; Brian R Clarridge; Manjusha Gokhale; Lauren Birenbaum; Stephen Hilgartner; Neil A Holtzman; David Blumenthal
Journal:  JAMA       Date:  2002 Jan 23-30       Impact factor: 56.272

2.  DNA patents and human dignity.

Authors:  D B Resnik
Journal:  J Law Med Ethics       Date:  2001       Impact factor: 1.718

3.  Diagnostic testing fails the test.

Authors:  Jon F Merz; Antigone G Kriss; Debra G B Leonard; Mildred K Cho
Journal:  Nature       Date:  2002-02-07       Impact factor: 49.962

4.  Science and the law. Working through the patent problem.

Authors:  John P Walsh; Wesley M Cohen; Ashish Arora
Journal:  Science       Date:  2003-02-14       Impact factor: 47.728

5.  Science and the law. Patent swords and shields.

Authors:  Rebecca S Eisenberg
Journal:  Science       Date:  2003-02-14       Impact factor: 47.728

6.  Secrecy is increasing in step with competition.

Authors:  John P Walsh; Wei Hong
Journal:  Nature       Date:  2003-04-24       Impact factor: 49.962

7.  History of a gene patent: tracing the development and application of commercial BRCA testing.

Authors:  Bryn Williams-Jones
Journal:  Health Law J       Date:  2002

Review 8.  Scope and impact of financial conflicts of interest in biomedical research: a systematic review.

Authors:  Justin E Bekelman; Yan Li; Cary P Gross
Journal:  JAMA       Date:  2003 Jan 22-29       Impact factor: 56.272

9.  Effects of patents and licenses on the provision of clinical genetic testing services.

Authors:  Mildred K Cho; Samantha Illangasekare; Meredith A Weaver; Debra G B Leonard; Jon F Merz
Journal:  J Mol Diagn       Date:  2003-02       Impact factor: 5.568

10.  The gene patenting controversy: a convergence of law, economic interests, and ethics.

Authors:  D J Kevles; A Berkowitz
Journal:  Brooklyn Law Rev       Date:  2001
View more
  26 in total

1.  Open biotechnology: licenses needed.

Authors:  Yann Joly
Journal:  Nat Biotechnol       Date:  2010-05       Impact factor: 54.908

2.  Are the gene-patent storm clouds dissipating? A global snapshot.

Authors:  Johnathon Liddicoat; Tess Whitton; Dianne Nicol
Journal:  Nat Biotechnol       Date:  2015-04       Impact factor: 54.908

Review 3.  The fate and future of patents on human genes and genetic diagnostic methods.

Authors:  Isabelle Huys; Gert Matthijs; Geertrui Van Overwalle
Journal:  Nat Rev Genet       Date:  2012-05-18       Impact factor: 53.242

4.  The helix in the labyrinth: do we need genetic health services and policy research?

Authors:  Fiona Alice Miller; Brenda Wilson; Jeremy Grimshaw; Renaldo Battista; Ingeborg Blancquaert; June C Carroll; François Rousseau; Barbara Slater
Journal:  Healthc Policy       Date:  2008-08

5.  Patents versus patenting: implications of intellectual property protection for biological research.

Authors:  Zhen Lei; Rakhi Juneja; Brian D Wright
Journal:  Nat Biotechnol       Date:  2009-01       Impact factor: 54.908

6.  Legal uncertainty in the area of genetic diagnostic testing.

Authors:  Isabelle Huys; Nele Berthels; Gert Matthijs; Geertrui Van Overwalle
Journal:  Nat Biotechnol       Date:  2009-10       Impact factor: 54.908

7.  It's about scientific secrecy, dummy: a better equilibrium among genomics patenting, scientific research and health care.

Authors:  Miriam Bentwich
Journal:  Sci Eng Ethics       Date:  2011-02-13       Impact factor: 3.525

8.  Changing the rules of the game: addressing the conflict between free access to scientific discovery and intellectual property rights.

Authors:  Miriam Bentwich
Journal:  Nat Biotechnol       Date:  2010-02       Impact factor: 54.908

Review 9.  An empirical review of major legislation affecting drug development: past experiences, effects, and unintended consequences.

Authors:  Aaron S Kesselheim
Journal:  Milbank Q       Date:  2011-09       Impact factor: 4.911

10.  Harm, hype and evidence: ELSI research and policy guidance.

Authors:  Timothy Caulfield; Subhashini Chandrasekharan; Yann Joly; Robert Cook-Deegan
Journal:  Genome Med       Date:  2013-03-26       Impact factor: 11.117
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.